Luke M. Beshar, Director at Protara Therapeutics, Inc. (TARA), bought 10,000 shares at $4.25 ($43K) on 2022-03-14, disclosed to the SEC on 2022-03-16.
Open-market purchase of $42k TARA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| RGNX | SELL | 2018-12-03 | $831K | — | Filing → |
| RGNX | SELL | 2018-11-28 | $2.6M | — | Filing → |
| RGNX | SELL | 2018-11-21 | $3.9M | — | Filing → |